
Regeneron Spends $570K Lobbying Amid Drug Pricing Wars
Pharmaceutical patent reform drives Regeneron’s $570K Q3 lobbying as Congress advances bipartisan bills targeting pay-for-delay settlements and patent extensions.
Data and News Shaping the Political Landscape

Pharmaceutical patent reform drives Regeneron’s $570K Q3 lobbying as Congress advances bipartisan bills targeting pay-for-delay settlements and patent extensions.

CVS Health spent $2.15M lobbying on PBM reform legislation as Congress advances bipartisan bills to overhaul pharmacy benefit manager practices and pricing models.

AMA spent $4.62M in Q3 2025 lobbying on Medicare physician payment reform, GME expansion, and telehealth policy as Congress considers bipartisan legislation.

AIADA’s automotive lobbying efforts deploy $870,000 in Q3 2025 to fight tariffs, emissions standards, and tax policy threatening 9,500 international dealers.

BlackRock’s digital asset lobbying reached $740K in Q3 2025, targeting cryptocurrency regulation, retirement policy, and AI as Congress reshapes financial rules.

Morgan Stanley spent $620,000 on digital asset lobbying in Q3 2025, focusing on SEC-CFTC oversight frameworks, international trade policy, and tax certainty.

Cargo theft lobbying by UPS targets organized retail crime legislation as the company spent $1.3M in Q3 2025 on cargo security and customs modernization.

Comcast’s broadband lobbying hit $3.08M in Q3 2025 as the telecom giant deployed 13 in-house lobbyists to shape BEAD implementation, spectrum policy, and AI regulation.

OpenAI copyright lobbying intensifies with $920K Q3 spending as Congress debates whether AI training practices constitute intellectual property theft.

Venture capital lobbying by NVCA hits $648K in Q3 2025, targeting capital formation, crypto regulation, and immigration reform amid mixed congressional momentum.

Generic drug patent reform gains momentum as AAM spends $640K lobbying Congress to eliminate pay-for-delay settlements and patent thickets costing Medicare billions.

Alcoa Corporation spent $710,000 lobbying on aluminum industry lobbying priorities: IRA tax credits, tariffs, and critical minerals development amid U.S.-China competition.

Hotel industry lobbying by AHLA reached $840,000 in Q3 2025, targeting labor regulations, fee transparency rules, and immigration policy reforms.

Aluminum tariffs lobbying drives Anheuser-Busch’s $1.32M Q3 spending as doubled tariffs threaten beer can costs, while TCJA provisions expire and cannabis regulation advances.

Hospital lobbying intensifies as Federation of American Hospitals spends $725K targeting Medicare reform, rural hospital funding, and workforce shortages in Q3 2025.

Ford’s EV lobbying strategy intensifies as the automaker spent $727,346 in Q3 2025 navigating expired tax credits, supply chain threats, and regulatory uncertainty.

Healthcare lobbying by Elevance Health reached $2.04M in Q3 2025 as Congress scrutinizes Medicare Advantage costs and advances bipartisan PBM reform legislation.

Intuit’s tax policy lobbying reaches $900K in Q3 2025 as the company defends TurboTax against IRS Direct File while positioning for AI-driven fintech growth.

Hedge fund lobbying by the Managed Funds Association intensified in Q3 2025 with $1.18M spent on digital assets, carried interest, and retirement plan access.

Restaurant industry lobbying intensifies as the National Restaurant Association spent $810,000 in Q3 2025 fighting for tax relief, immigration reform, and labor protections.